Genenta Science SPA
GNTA
查看詳細走勢圖
0.732USD
-0.006-0.79%
收盤 02/06, 16:00（美東）報價延遲15分鐘
14.02M總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.79%
5天
-25.79%
1月
-48.81%
6月
-80.74%
今年開始到現在
-50.87%
1年
-81.42%
查看詳細走勢圖
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
Genenta Science SPA新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Genenta Science SPA簡介
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
公司代碼GNTA
公司Genenta Science SPA
CEOParacchi (Pierluigi)
網址https://www.genenta.com/
相關品種
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%熱門品種
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
70775.610
+805.480 (+1.15%)
282.580
+22.390 (+8.61%)
2086.910
+35.180 (+1.71%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
